Source: Wikipedia, the free encyclopedia.
Norverapamil
|
Names
|
IUPAC name
(RS)-2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethylamino]-2-isopropylpentanenitrile
|
Identifiers
|
|
|
|
|
ChEBI
|
|
ChemSpider
|
|
ECHA InfoCard
|
100.060.476
|
EC Number
|
|
|
|
UNII
|
|
|
|
InChI=1S/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3 NKey: UPKQNCPKPOLASS-UHFFFAOYSA-N NInChI=1/C26H36N2O4/c1-19(2)26(18-27,21-9-11-23(30-4)25(17-21)32-6)13-7-14-28-15-12-20-8-10-22(29-3)24(16-20)31-5/h8-11,16-17,19,28H,7,12-15H2,1-6H3 Key: UPKQNCPKPOLASS-UHFFFAOYAQ
|
|
Properties
|
|
C26H36N2O4
|
Molar mass
|
440.584 g·mol−1
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
Chemical compound
Norverapamil is a calcium channel blocker. It is the main active metabolite of verapamil.[1]
References
VDCCsTooltip Voltage-dependent calcium channels
| |
---|
VGKCsTooltip Voltage-gated potassium channels | |
---|
IRKsTooltip Inwardly rectifying potassium channel | |
---|
KCaTooltip Calcium-activated potassium channel | |
---|
K2PsTooltip Tandem pore domain potassium channel | |
---|
VGSCsTooltip Voltage-gated sodium channels | |
---|
ENaCTooltip Epithelial sodium channel | |
---|
ASICsTooltip Acid-sensing ion channel | |
---|
CaCCsTooltip Calcium-activated chloride channel | |
---|
CFTRTooltip Cystic fibrosis transmembrane conductance regulator | |
---|
Unsorted | |
---|
Others | Tooltip Transient receptor potential channels | |
---|
Tooltip Ligand gated ion channels | |
---|
|
---|
|